About Cascara Ventures
Cascara Ventures is a venture capital firm founded in 2010. It is primarily based out of Brussels, Belgium. As of May 2025, Cascara Ventures has invested in 10 companies. It primarily invests in Series A round in Germany based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Series A round of Surgify Overall, Cascara Ventures portfolio has seen 2 acquisitions, namely Fiagon and xbird. A lot of funds co-invest with Cascara Ventures, with names like ISB sharing a substantial percentage of its portfolio. Cascara Ventures has team of 1 people including 1 partners.Key Metrics
Cascara Ventures' List of Top Investments
Cascara Ventures has a portfolio of 10 companies. Their most notable investments are in Smart Reporting and Meidrix.Their portfolio spans across Germany, Finland and Netherlands. They have invested in HealthTech, Life Sciences, Enterprise Applications, across Series A, Seed and 1 more. Here is the list of top investments by Cascara Ventures:Provider of AI-based radiology platform for patient data mining. The browser-based, vendor-neutral system does not require any installation. Radiologists can generate the report directly from a workstation without entering any sensitive patient data.
Key facts about Smart Reporting
- Founded Year: 2014
- Location: Munich (Germany)
- Stage: Series C
- Total Funding till date: $47.4M
- Employee Count: 135 as on May 31, 2026
- Investors: Wessel Management, European Investment Bank and 44 Others
- Latest Funding Round: Series C, Apr 22, 2024, $*****
- Highlight: Editors' Pick
2. Desentum
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. By studying the molecular mechanism of the hypersensitivity reaction, the company has made discoveries that allow for improved design of immunotherapeutic products against common types of allergies. The company will be starting clinical trials for the first hypoallergens in 2017.
Key facts about Desentum
- Founded Year: 2011
- Location: Espoo (Finland)
- Stage: Series C
- Total Funding till date: $26.7M
- Employee Count: 14 as on Jul 31, 2026
- Investors: EIC Fund, European Innovation Council and 4 Others
- Latest Funding Round: Series C, Feb 20, 2024, $*****
- Highlight: Editors' Pick
3. ATRO Medical
Developer of a polymer-based meniscus implant. The company has developed Trammpolin, a synthetic, non-resorbable anatomically shaped polymer-based meniscus implant for restoring the protective function of the meniscus by acting as a joint spacer. It reduces pain and restores mobility.
Key facts about ATRO Medical
- Founded Year: 2016
- Location: Nijmegen (Netherlands)
- Stage: Series A
- Total Funding till date: $5.68M
- Employee Count: 12 as on Aug 31, 2026
- Investors: Thuja Capital, EIC Fund and 13 Others
- Latest Funding Round: Series A, Feb 24, 2026, $*****
- Highlight: Editors' Pick
4. Surgify
Surgify develops solutions to protect soft tissue structures while bones are being cut or removed during surgery and prevent associated complications. The software assists providers to avoid bleeding, infections, and nerve injuries which can be complications for the patient. The technology used by the company claims to improve the safety, speed, and precision of bone surgery to minimize these risks.
Key facts about Surgify
- Founded Year: 2015
- Location: Espoo (Finland)
- Stage: Series A
- Total Funding till date: $9.69M
- Employee Count: 25 as on Sep 30, 2026
- Investors: EIC Fund, Innovestor and 8 Others
- Latest Funding Round: Series A, May 27, 2025, $*****
- Highlight: Editors' Pick

5. Fiagon
Manufacturer of electromagnetic navigation systems for ear and sinus surgery. These systems facilitate surgical procedures by providing tracking for instruments during medical interventions. The technology includes patient registration tools and flexible instruments that adapt to patient anatomy. These devices assist with tasks such as suction and probing during clinical operations.
Key facts about Fiagon
- Founded Year: 2007
- Location: Hennigsdorf (Germany)
- Stage: Acquired
- Total Funding till date: $8.5M
- Employee Count: 56 as on Aug 31, 2026
- Investors: German Startups Group, Brandenburg Capital and 4 Others
- Latest Funding Round: Series D, Mar 17, 2016, $*****
- Highlight: Acquired
Cascara Ventures' Year-on-Year Investment Trends
Cascara Ventures has invested in 10 companies over the last 15 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Surgify and most recent follow-on round was in ATRO Medical.Cascara Ventures' Investments by Stage
Cascara Ventures has made 6 investments in Series A stage with an average round size of $5.04M, 2 investments in Seed stage and 2 investments in Series B stage.Stage of entry | No. of Investments |
|---|---|
Series A | 6 |
Seed | 2 |
Series B | 2 |
Note: We have considered here, only first round of investments
Cascara Ventures' Investments by Sector
Cascara Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, Vertical SaaS and Artificial Intelligence - Industry Applications. Notably, it has invested in 10 Tech companies, 9 Enterprise (B2B) companies, 6 Software companies and at least 3 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 7 |
Enterprise Applications | 5 |
HealthTech | 5 |
Vertical SaaS | 2 |
Artificial Intelligence - Industry Applications | 1 |
Note: We have considered here, only first round of investments
Cascara Ventures' Investments by Geography
Cascara Ventures has made most investments in Germany (7), followed by Finland where it has made 2 investments.Country | No. of Investments |
|---|---|
Germany | 7 |
Finland | 2 |
Netherlands | 1 |
Note: We have considered here, only first round of investments
Cascara Ventures' recent investments
Cascara Ventures has not made any investment in 2026 so far.Here are the most recent investments by Cascara Ventures:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 27, 2025 | Finland | Series A | 2180 | [+1] | |
Dec 14, 2021 | Netherlands | Series A | 4447 | [+3] | |
Jul 17, 2017 | Netherlands | Series A | 6096 | [+4] | |
Apr 11, 2017 | Germany | Series A | 9023 | [+1] | |
Jan 23, 2017 | Finland | Series A | 5117 |
Acquired companies in Cascara Ventures' Portfolio
2 companies from Cascara Ventures' portfolio have been acquired. The most recent acquisition was Fiagon in May 2022 by Hemostasis for $*****.Here are Cascara Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 13, 2022 | 2012 | Series B | 4714 | |
Jan 31, 2022 | 2016 | Series A | 9653 |
Team profile of Cascara Ventures
Cascara Ventures has a team of 1 member located in Belgium. Cascara Ventures' team does not sit on the board of any company as of now.Co-investors of Cascara Ventures
Over the past 15 years, 48 investors have co-invested in Cascara Ventures's portfolio companies. This includes funds and angels.
- Invested before Cascara Ventures: HTGF, Bmbf and 12 others have invested in rounds before Cascara Ventures. There are 4 companies where HTGF has invested before Cascara Ventures and 1 company where Bmbf has invested before Cascara Ventures.
- Top Co-investors of Cascara Ventures: 11 investors entered a company along with Cascara Ventures. These include investors like ISB (1 company).
- Invested after Cascara Ventures: A total of 23 investors have invested in Cascara Ventures's portfolio after their investments. Top Investors include EIC Fund (3 companies), Europa (2 companies) and Wessel Management (1 company).
Recent News related to Cascara Ventures
•
Surgify Medical Secures €7M in Series A FundingCision•May 27, 2025•Surgify, ZEISS, European Innovation Council, Cascara Ventures
•
Digital Pathology Image Analysis Software Provider microDimensions Raises Funding |FinSMEsFinSMEs•Jul 18, 2016•microDimensions, HTGF, Bayern Kapital, Cascara Ventures
•
microDimensions GmbH successfully closes seed round | High-Tech GründerfondsHTGF•Mar 07, 2014•microDimensions, HTGF, Bayern Kapital, Cascara Ventures
